TCM Biotech International Corp. (TPEX:4169)

TCM Biotech International Revenue

TCM Biotech International had revenue of 336.59M TWD in the half year ending December 31, 2024, a decrease of -21.63%. This brings the company's revenue in the last twelve months to 674.43M, down -19.16% year-over-year. In the year 2024, TCM Biotech International had annual revenue of 666.53M, down -31.26%.

• Revenue (ttm): 674.43M
• Revenue Growth: -19.16%
• P/S Ratio: 8.80
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 5.93B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	666.53M	-303.09M	-31.26%
Dec 31, 2023	969.62M	167.20M	20.84%
Dec 31, 2022	802.42M	100.38M	14.30%
Dec 31, 2021	702.05M	-35.03M	-4.75%
Dec 31, 2020	737.08M	168.45M	29.62%